Breier, Alan

Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence from a novel positron emission tomography method

Breier, A., Su, T.-P., Saunders, R., Carson, R. E., Kolachana, B. S., de Bartolomeis, A., Weinberger, D. R., Weisenfeld, N., Malhotra, A. K., Eckelman, W. C., et al. (1997) · Proceedings of the National Academy of Sciences

Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior

Cited by 1,154

Efficacy of Olanzapine and Olanzapine-Fluoxetine Combination in the Treatment of Bipolar I Depression

Tohen, M., Vieta, E., Calabrese, J., Ketter, T. A., Sachs, G., Bowden, C., Mitchell, P. B., Centorrino, F., Risser, R., Baker, R. W., et al. (2003) · Archives of General Psychiatry

Bipolar Disorder and TreatmentTreatment of Major Depression

Cited by 908

National Institute of Mental Health Longitudinal Study of Chronic Schizophrenia: Prognosis and Predictors of Outcome

Breier, A. (1991) · Archives of General Psychiatry

Schizophrenia research and treatmentMental Health and Psychiatry

Cited by 626

Randomized, Double-Blind Trial of Olanzapine Versus Placebo in Patients Prodromally Symptomatic for Psychosis

McGlashan, T. H., Zipursky, R. B., Perkins, D., Addington, J., Miller, T., Woods, S. W., A. Hawkins, K., E. Hoffman, R., Preda, A., Epstein, I., et al. (2006) · American Journal of Psychiatry

Schizophrenia research and treatmentBipolar Disorder and Treatment

Cited by 556

Brain Morphology and Schizophrenia: A Magnetic Resonance Imaging Study of Limbic, Prefrontal Cortex, and Caudate Structures

Breier, A. (1992) · Archives of General Psychiatry

Schizophrenia research and treatmentMental Health and Psychiatry

Cited by 513

Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers

Breier, A. F., Malhotra, A. K., Pinals, D. A., Weisenfeld, N., & Pickar, D. (1997) · American Journal of Psychiatry

Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior

Cited by 392

Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects

Krystal, J. H., Abi-Saab, W., Perry, E., D’Souza, D. C., Liu, N., Gueorguieva, R., McDougall, L., Hunsberger, T., Belger, A., Levine, L., et al. (2005) · Psychopharmacology

Neuroscience and Neuropharmacology ResearchTreatment of Major Depression

Cited by 272

The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis

Miller, T. J., Zipursky, R. B., Perkins, D., Addington, J., Woods, S. W., Hawkins, K. A., Hoffman, R., Preda, A., Epstein, I., Addington, D., et al. (2003) · Schizophrenia Research

Schizophrenia research and treatmentBipolar Disorder and Treatment

Cited by 150

Disturbed resting state eeg synchronization in bipolar disorder: A graph-theoretic analysis

Kim, D.-J., Bolbecker, A. R., Howell, J., Rass, O., Sporns, O., Hetrick, W. P., Breier, A., & O'Donnell, B. F. (2013) · NeuroImage Clinical

Functional Brain Connectivity StudiesBipolar Disorder and Treatment

Cited by 141

The Effects of Olanzapine in Reducing the Emergence of Psychosis Among Nursing Home Patients With Alzheimer's Disease

Clark, W. S., Street, J. S., Feldman, P. D., & Breier, A. (2001) · The Journal of Clinical Psychiatry

Dementia and Cognitive Impairment ResearchSchizophrenia research and treatment

Cited by 101

Metacognitive Capacity as a Predictor of Insight in First-Episode Psychosis

Vohs, J. L., Lysaker, P. H., Liffick, E., Francis, M. M., Leonhardt, B. L., James, A., Buck, K. D., Hamm, J. A., Minor, K. S., Mehdiyoun, N., et al. (2015) · Journal of Nervous & Mental Disease

Schizophrenia research and treatmentMental Health and Psychiatry

Cited by 47